Effect of Subcutaneous Recombinant Human Erythropoetin in Cancer Patients Receiving Radiotherapy: Final Report of a Randomized, Open-Labelled, Phase II Trial
British Journal of Cancer - United Kingdom
doi 10.1038/bjc.1998.331
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 1998
Authors
Publisher
Springer Science and Business Media LLC